Article citationsMore>>

A. Ravaud and M. Sire, “Arterial Hypertension and Clinical Benefit of Sunitinib, Sorafenib and Bevacizumab in First and Second-Line Treatment of Metastatic Renal Cell Cancer,” Annals of Oncology, Vol. 20, No. 5, 2009, pp. 966-967. http://dx.doi.org/10.1093/annonc/mdp201

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top